Annual Working Capital
$227.18 M
+$63.24 M+38.58%
December 31, 2023
Summary
- As of February 10, 2025, FUSN annual working capital is $227.18 million, with the most recent change of +$63.24 million (+38.58%) on December 31, 2023.
- During the last 3 years, FUSN annual working capital has risen by +$10.87 million (+5.02%).
Performance
FUSN Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Working Capital
$200.16 M
-$27.01 M-11.89%
March 31, 2024
Summary
- As of February 10, 2025, FUSN quarterly working capital is $200.16 million, with the most recent change of -$27.01 million (-11.89%) on March 31, 2024.
- Over the past year, FUSN quarterly working capital has increased by +$14.37 million (+7.74%).
Performance
FUSN Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
FUSN Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +38.6% | +7.7% |
| 3 y3 years | +5.0% | +7.7% |
| 5 y5 years | +693.3% | +7.7% |
FUSN Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -27.8% | -11.9% | -18.1% |
| 5 y | 5-year | at high | -72.6% | -36.0% | -69.1% |
| alltime | all time | at high | -87.4% | -36.0% | -69.1% |
Fusion Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $200.16 M(-11.9%) |
| Dec 2023 | $227.18 M(+38.6%) | $227.18 M(+22.3%) |
| Sep 2023 | - | $185.79 M(-2.6%) |
| Jun 2023 | - | $190.77 M(-6.2%) |
| Mar 2023 | - | $203.30 M(+24.0%) |
| Dec 2022 | $163.93 M(-17.7%) | $163.93 M(-19.0%) |
| Sep 2022 | - | $202.43 M(+3.5%) |
| Jun 2022 | - | $195.50 M(+1.5%) |
| Mar 2022 | - | $192.59 M(-3.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $199.25 M(-7.9%) | $199.25 M(+5.2%) |
| Sep 2021 | - | $189.45 M(+7.8%) |
| Jun 2021 | - | $175.79 M(-22.3%) |
| Mar 2021 | - | $226.24 M(+4.6%) |
| Dec 2020 | $216.31 M(+247.3%) | $216.31 M(-25.8%) |
| Sep 2020 | - | $291.57 M(-6.7%) |
| Jun 2020 | - | $312.52 M(+404.5%) |
| Mar 2020 | - | $61.95 M(-0.5%) |
| Dec 2019 | $62.28 M(+117.5%) | $62.28 M |
| Dec 2018 | $28.64 M | - |
FAQ
- What is Fusion Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Fusion Pharmaceuticals?
- What is Fusion Pharmaceuticals annual working capital year-on-year change?
- What is Fusion Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Fusion Pharmaceuticals?
- What is Fusion Pharmaceuticals quarterly working capital year-on-year change?
What is Fusion Pharmaceuticals annual working capital?
The current annual working capital of FUSN is $227.18 M
What is the all time high annual working capital for Fusion Pharmaceuticals?
Fusion Pharmaceuticals all-time high annual working capital is $227.18 M
What is Fusion Pharmaceuticals annual working capital year-on-year change?
Over the past year, FUSN annual working capital has changed by +$63.24 M (+38.58%)
What is Fusion Pharmaceuticals quarterly working capital?
The current quarterly working capital of FUSN is $200.16 M
What is the all time high quarterly working capital for Fusion Pharmaceuticals?
Fusion Pharmaceuticals all-time high quarterly working capital is $312.52 M
What is Fusion Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, FUSN quarterly working capital has changed by +$14.37 M (+7.74%)